AstraZeneca board rejects Pfizer's sweetened proposal

11:57 AM | May 2, 2014 | Natasha Alperowicz

AstraZeneca says that its board today rejected Pfizer's proposal to combine the two firms. "The financial and other terms described in the proposal are inadequate, substantially undervalue AstraZeneca...